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Characteristics of velopharyngeal
dysfunction in 22q11.2 deletion syndrome:
a retrospective case-control study
Sebastiano Failla1, Peng You2, Chandheeb Rajakumar2, Anne Dworschak-Stokan3, Philip C. Doyle4 and
Murad Husein2*

Abstract
Objective: To identify and describe the dynamic features of velopharyngeal dysfunction (VPD) in patients with
22q11.2 deletion syndrome relative to patients with non-syndromic cleft palates.
Study design: Retrospective case-control study.
Setting: Pediatric tertiary care center.
Subjects and methods: A total of 30 children (aged 9–16 years) with VPD were included in this study. Fifteen
children with a definitive diagnosis of 22q11.2 deletion syndrome requiring surgical VPD repair were included in the
22q11.2 deletion syndrome group. Fifteen age- and sex-matched children with non-syndromic cleft palate requiring
surgical VPD repair were included in the non-syndromic cleft palate group for comparison. Velar displacement,
lateral pharyngeal wall displacement, and lateral pharyngeal wall motion pattern data were extracted from
preoperative Multiview Videofluoroscopy imaging studies of all children and compared across groups.
Results: Lateral pharyngeal wall displacement was found to be reduced in the 22q11.2 deletion syndrome group
(U = 29.50, p = .001, r = .63). However, measures of velar displacement were not observed to differ between groups.
Similarly, lateral pharyngeal wall motion pattern distributions were not found to differ across these two groups.
Conclusions: Velopharyngeal dysfunction in patients with 22q11.2 deletion syndrome showed differences in
dynamic velopharyngeal function when compared to non-syndromic cleft palate patients. The current findings
provide initial insights into the unique aspects of velopharyngeal dysfunction for patients with 22q11.2 deletion
syndrome. These findings may guide further efforts directed toward understanding the dynamic velopharyngeal
characteristics of this population and potentially optimize surgical management and functional outcomes.
Keywords: 22q11.2 deletion, Non-syndromic cleft palate, Velopharyngeal dysfunction, Velopharyngeal insufficiency
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Introduction
As a clinical diagnostic group, 22q11.2 deletion syndrome
(22q11.2DS) is the most commonly identified human
microdeletion syndrome with an estimated prevalence of
1 in 2000 to 7000 people [1–3]. Although it may be acquired via an autosomal dominant inheritance pattern, it
most often occurs sporadically through a de novo mutation [4–6]. Before its genomic basis was explicitly defined,
the eclectic clinical presentations of those with 22q11.2DS
led to its description as a variety of clinical entities including DiGeorge syndrome, velocardiofacial syndrome, and
conotruncal anomaly face syndrome. However, it is now
known that its distinct multi-systemic clinical features
(e.g., almond-shaped eyes, bulbous nasal tip, cardiac defects, immunodeficiency, developmental delays, psychiatric disorders, endocrine abnormalities, and palatal
defects) are the result of the deletion of band q11.2 of
chromosome 22 [7–12].
The majority of those identified with 22q11.2DS
present with palatal defect-related velopharyngeal dysfunction (VPD) with a resultant range of abnormalities
in speech production [12, 13]. Anatomical and physiological anomalies including tonsillar hypertrophy, adenoid hypoplasia, platybasia, hypotonicity, congenital
velar shortening, and muscular abnormalities of the
pharynx have been documented and hypothesized as factors contributing to the relatively high incidence of VPD
among this specific population [1, 14–16]. Moreover, the
aforementioned studies have noted that both structural
and physiological deficits contribute to the presence of
VPD in individuals with 22q11.2DS.
One consistently uniform pattern of VPD has not yet
been documented. Thus, deficits related to VPD tend to
vary significantly in both presentation and perceived severity, an observation that is likely to be the result of the
variation in the velopharyngeal system and, subsequently,
VPD. It is important to note, however, there is a paucity
of literature regarding the range and complexity of the
changes that underlie velopharyngeal abnormalities and
their subsequent speech-related deficits specific to
22q11.2DS. Accordingly, the relatively rare nature of this
diagnostic entity combined with its considerable VPDrelated variability poses substantial clinical challenges in
identifying and describing deficits specific to this population. Despite its rarity, the ability to gather descriptive information about 22q11.2DS may benefit both clinical
classification and approaches to treatment.
Clinical information suggests that patients with VPD
secondary to 22q11.DS are treated similarly to patients
with non-syndromic cleft palate (NSCP) [17]. Regardless
of etiology, treatment goals are directed towards improving velopharyngeal closure [17]. More specifically, these
interventions seek to reduce the extent and impact of
structural abnormalities on speech production by
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employing surgical methods, where indicated, that facilitate improved velopharyngeal closure during deglutition
and phonation. Currently, there are several surgical approaches which have been shown to be effective interventions for VPD: posterior pharyngeal wall augmentation,
Furlow palatoplasty, pharyngeal flap, sphincter pharyngoplasty, or combined Furlow palatoplasty and sphincter
pharyngoplasty [17–21].
Despite similar surgical management, numerous studies have demonstrated that patients with 22q11.2DS
have inferior post-operative speech outcomes and higher
surgical revision rates when compared to patients with
NSCP [22, 23]. The cause for these differences in clinical
outcome has not yet been clearly identified but may
emerge from variations in the dynamic restrictions
underlying VPD in those with 22q11.2DS. Investigation
of the anatomical factors and dynamic features of the
velopharyngeal port in this specific patient population
may, therefore, facilitate improved understanding of surgical considerations unique to those with 22q11.2DS. Although it is suspicioned that poorer speech outcomes in
patients with 22q11.2DS are the result of multiple deficits that influence the velopharyngeal port, data to support this suggestion are currently limited. It is not
unreasonable to anticipate that the dynamic function of
the velopharyngeal port may be increasingly influenced as
more structures within this complex region are disrupted;
thus, speech deficits of 22q11.2DS may differ quantitatively from those that are more commonly noted in patients presenting with NSCP due to anatomical and
functional differences inherent to 22q11.2DS specifically.
Moreover, additional extensive functional disruptions in
the presence of altered anatomy may provide more significant management challenges for this specific population.
Information of this type would expand our knowledge
base relative to not only the presence and severity of VPD
in this population, but potentially the range of variability
that might exist and how this may influence speech.
Thus, exploration of an array of anatomical factors in
patients with 22q11.2DS-related VPD may facilitate both
improved understanding of the static and functional
changes unique to this specific population. These data
may be of substantial clinical benefit from both a diagnostic and management perspective and assist in understanding the underlying causes of the discrepant postsurgical
outcomes of patients with 22q11.2DS and NSCP undergoing VPD correction. Accordingly, the current study sought
to investigate differences in dynamic anatomical features
of VPD amongst patients with 22q11.2DS and NSCP.
More specifically, we sought to investigate how velar displacement (VD), lateral pharyngeal wall displacement
(LWD), and lateral pharyngeal wall motion pattern
(LWMP) differ amongst these two distinct patient populations. We anticipate that these data will serve to enhance
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currently limited knowledge regarding the unique challenges faced by this rare clinical entity and provide
insightful information which may be of clinical benefit
from both a diagnostic and treatment perspective.

Methods
Patients

A retrospective case-control study was conducted by
reviewing the medical records of patients who presented
to the VPD clinic at the London Health Sciences Centre
from 2001 to 2016. The study was approved by Western’s
Research Ethics Board (100970). The inclusion criteria for
the 22q11.2DS group consisted of 1) a definitive diagnosis
of 22q11.2DS with fluorescence in situ hybridization, 2)
the presence of VPD requiring surgical intervention, and
3) available preoperative Multiview Videofluoroscopy
(MVV) imaging. Age- and sex-matched patients with
NSCP were included for comparison. The inclusion criteria for the NSCP group consisted of 1) cleft palate, 2)
genetic assessment found to have no genetic syndrome, 3)
the presence of VPD requiring surgical intervention, and
4) availability of preoperative MVV imaging. No exclusion
criteria were set regarding the presence of comorbidities
or the type of cleft palate for either group.
Acquisition of Velopharyngeal Measures

VD, LWD, and LWMP measures were extracted from
the completed preoperative MVV imaging studies by a
single clinician (CR). All measurements were obtained
with a standard ruler from the frame with the greatest
degree of displacement during consonant-vowel productions according to the standardized measurement procedures described by Golding-Kushner [24].
LWMP was defined as the lateral pharyngeal wall contour or shape during phonation [25–27]. As previously described, possible shapes for classification included shelf,
balloon, vertical, and irregular [24]. VD was defined as the
displacement of the velum along its anterior-posterior
movement trajectory towards the posterior oropharyngeal
wall. Lastly, LWD was defined as the maximal medial excursion of the lateral pharyngeal wall.
All displacements were recorded as a proportion of
maximal theoretical displacement in each patient to
standardize velar and pharyngeal measures across all patients. More specifically, a VD of 0 indicated no velar
displacement towards the posterior oropharyngeal wall
during phonation, while a value of 1 indicated complete
anteroposterior velar closure (i.e., velar contact with the
posterior oropharyngeal wall). Similarly, an LWD value
of 0 indicated no transverse displacement of the lateral
pharyngeal wall towards the opposite lateral wall of the
pharynx; an LWD value of 1 represented the maximum
theoretical LWD (i.e., complete medial excursion extending toward the opposite lateral pharyngeal wall); a
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LWD of 0.5 corresponded to the midline of the pharynx.
In cases where the LWD was asymmetrical, the side with
the greatest degree of displacement was identified.
The collective findings of past explorations confirm
that variability in the structural shape and associated
movement of the velopharyngeal port is to be expected
[25–27]. With this information in mind, it may be reasoned that objective measurement of area and displacement lends itself ideally to use of this type of ratio index.
Accordingly, data was obtained in such a standardized
manner to permit direct comparison between populations without confounds associated with expected variability in velopharyngeal cross-sectional area [28, 29].
Data analysis

Group comparisons of VD and LWD were conducted by
two separate Mann-Whitney U tests. Between-group differences of LWMP distributions were assessed with a Fisher’s
Exact Test. In an explicit effort to reduce interpretive errors, a Bonferroni correction was applied to control for
alpha inflation related to multiple hypothesis testing. Thus,
significance was assessed at α = 0.017. All statistical analyses
were conducted using IBM SPSS statistics software package
version 25 (IBM Corp., Armonk, N.Y., USA).

Results
Sixteen patients with 22q11.2DS who underwent preoperative MVV imaging for surgical VPD correction
were identified. One was excluded due to poor MVV
quality related to patient age and cooperation, resulting
in 15 (7 males; 8 females) patients. Fifteen age- and sexmatched controls with NSCP-related VPD who underwent preoperative MVV imaging studies were included
for comparison. Thus, a total of 30 patient records were
reviewed for the current study. A summary of patient
characteristics stratified by group is presented in Table 1.
Distributions of VD and LWD measures are shown in
Fig. 1. The mean age of participants was 9.0 and 9.4
years for the 22q11.2DS and NSCP groups, respectively.
Both groups ranged from 4 to 16 years of age. Most patients across both groups were observed to exhibit a
balloon-type LWMP (n = 22); the remainder exhibited a
shelf-type pattern (n = 8).
Seven patients (46.7%) presented with a balloon-type
LWMP and 8 (53.3%) showed a shelf-type LWMP in the
22q11.2DS group. In contrast, only two patients (13.3%)
in the NSCP group showed a balloon-type LWMP; the
remaining 13 NSCP patients (86.7%) showed a shelf-type
LWMP. Although balloon-type LWMP appeared to be
more common in patients with 22q11.2DS, betweengroup differences in distribution did not achieve statistical significance based on the Bonferroni-adjusted alpha
of 0.017 (OR 12.25, p = .04). Similarly, there was no significant between-group difference in VD (0.86 vs. 0.80)
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Table 1 Patient characteristics stratified by group
22q11.2DS

NSCP

Patient

Age

Sex

LWD

LWMP

VD

Patient

Age

Sex

LWD

LWMP

VD

1

5

F

0.28

S

0.86

16

7

F

0.41

S

0.90

2

5

F

0.40

S

0.94

17

6

F

0.34

B

0.54

3

5

F

0.45

S

0.55

18

7

F

0.48

S

0.54

4

14

F

0.20

B

0.83

19

14

F

0.49

S

0.67

5

5

F

0.19

B

0.68

20

6

F

0.43

S

0.70

6

5

F

0.24

S

0.94

21

5

F

0.43

S

0.95

7

4

M

0.15

B

0.16

22

4

M

0.39

S

0.55

8

11

M

0.13

S

0.95

23

10

M

0.49

S

0.87

9

14

F

0.35

S

0.84

24

15

F

0.33

S

0.91

10

16

M

0.27

B

0.80

25

16

M

0.50

S

0.88

11

13

M

0.18

B

0.95

26

13

M

0.47

S

0.80

12

16

F

0.45

S

0.87

27

16

F

0.42

S

0.87

13

7

M

0.34

S

0.86

28

5

M

0.43

S

0.77

14

7

M

0.11

B

0.18

29

8

M

0.42

S

0.65

15

8

M

0.15

B

0.95

30

9

M

0.31

B

0.83

Range

0.11–0.45

0.16–0.95

0.33–0.50

0.54–0.95

Mean

9.0

0.26

0.76

9.4

0.42

0.76

SD

4.3

0.11

0.25

4.1

0.06

0.14

Median

7.0

0.24

0.86

8.0

0.43

0.80

IQR

8.5

0.18

0.20

7.5

0.08

0.22

Note. 22q11.2DS: 22q11.2 Deletion Syndrome; Shape of Pharyngeal Wall: Balloon (B), Shelf (S); LWD: lateral pharyngeal wall displacement; LWMP: lateral
pharyngeal wall motion pattern; VD: velar displacement; NSCP: non-syndromic cleft palate; SD: standard deviation; IQR: Interquartile Range

Fig. 1 Distribution of lateral pharyngeal wall and velar displacement measures by group. 22q11.2DS: 22q11.2 Deletion Syndrome; LWD: lateral
pharyngeal wall displacement; NSCP: non-syndromic cleft palate; VD: velar displacement
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(U = 93, p = .42, r = .15). In contrast, however, LWD was
significantly more restricted in the 22q11.2DS group as
compared to the NSCP group (0.24 vs. 0.43, respectively)
(U = 29.50, p = .001, r = .63).

Discussion
This study was conducted to identify and describe dynamic
velopharyngeal function in patients with VPD associated
with 22q11.2DS and NSCP. To aid in the interpretation of
the results, data from age- and sex-matched NSCP patients
requiring VPD correction were collected and used as a
point of reference. We acknowledge that the use of those
with NSCP-related VPD as a control group carries considerable restrictions; however, we intentionally chose this
group for a basis of comparison in an attempt to better
understand the nature of VPD and the potential dynamic
differences underlying the discrepant postsurgical outcomes
between 22q11.2DS and NSCP VPD repair. Thus, these
two clinical groups were assessed with an a priori assumption that patients with NSCP-related VPD could provide a
“point of reference” from which unique patterns of variability might be detected.
Based on our data, VPD patients with 22q11.2DS exhibited significant differences in dynamic velopharyngeal
function as seen on MVV compared to those with
NSCP. However, the significance should not be interpreted to indicate that two distinct groups exist; rather,
we believe the current data support the assumption that
those with 22q11.2DS may exhibit variation in VPD relative to those with NSCP.
A salient finding from our study is that those with
22q11.2DS exhibited LWDs that were reduced by almost
half compared to that identified for the VPD control
group (0.24 vs. 0.43).
Inadequate velopharyngeal closure results in velopharyngeal incompetence which can manifest as speech
hypernasality, decreased speech intelligibility, and inappropriate nasal emissions. It is well-documented that
variability in the broader diagnostic category of “VPD” is
substantial [25–27]. However, we also believe that the
ability to describe and further develop datasets on particular subgroups of those with VPD is essential in order
to better understand the deficits. From the standpoint of
speech production, minor changes in structure and function of this dynamic region may create substantial reductions in the effectiveness of not only VP closure, but
the end-product of speech that is produced. It is our
opinion that if the extent of deficits can be quantified,
more exact prospective studies on the evolution of the
problem, as well as the ability to monitor post-treatment
outcomes will be enhanced.
It is important to note, however, that the external validity of the present data must be viewed with caution.
This comment is raised due to two specific issues. First,
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in the present work, those with VPD secondary to NSCP
were selected and used as a point of reference in the
current descriptive exploration. Secondly, the sample
size used is indeed small and with that comes the potential for differences to emerge with larger participant
samples. However, we feel that the ability to carefully
describe metrics in relatively rare populations allows for
the generation of more specific questions about VPD in
these populations. These data support the notion that
LWD measures can serve to distinguish distinct subpopulations with abnormalities of the velopharyngeal system. Moreover, they provide a plausible rationale for the
observed differences in the functional postoperative outcomes of those with 22q11.2DS and other groups with
VPD. Hence, the present data provide a valuable, initial
index of how this relatively rare syndrome compares to
others with a similar deficit in VP functioning.
The current study also demonstrated a lack of velar displacement differences between the groups assessed. To
fully appreciate this result, it should be noted that the
22q11.2DS patients were compared to those with cleft palate, rather than those secondary to a syndrome. Since
NSCP patients would be expected to have lower than normal VD measures, we can extrapolate with some level of
confidence that the 22q11.2DS patients would also have
diminished VD than that which would be expected from
the normal population. The combination of decreased
LWD and less-than-expected VD may, at least in part,
contribute to lowered success rates following surgery. Yet
we must clearly acknowledge that additional data from a
larger number of participants is necessary.
Treatment of VPD in patients with 22q11.2DS presents a unique challenge. Widdershoven et al. [23] reported a 16% revision rate in the 22q11.2DS compared
to 0% in patients without, with the latter group also
showing better outcomes on endoscopy and auditoryperceptual assessment of speech postoperatively. The patients examined by Widdershoven et al. all had initial
palatal lengthening procedure whereas the revision was
performed using sphincter pharyngoplasty. Similarly,
Losken et al. [22] described their revision rate in
22q11.2DS patients to be significantly higher than in
those without (22% vs 11%). For Losken et al., all of the
patients studied underwent primary sphincter pharyngoplasty. The authors noted that patients who required revision of pharyngoplasty were more likely to have larger
velopharyngeal areas. The higher revision rates, therefore, invite the search for intrinsic patient characteristics
in patients with 22q11.2DS that may impact their postoperative outcome. Extrapolating from our results, it is
possible that the decreased lateral wall movement hinders the patient’s ability to close the ports following a
pharyngeal flap. The lack of dynamic closure in turn
leads to unsatisfactory postoperative results. Hence,
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22q11.2DS patients may benefit from a wider pharyngeal
flap to compensate for the decreased dynamic lateral
wall movement. Conversely, sphincter pharyngoplasty
relies less on the existing lateral wall movement; instead,
it narrows the velopharynx and may compliment the dynamic limitations seen in 22q11.2DS patients. The results of this study should be interpreted as to highlight
dynamic differences in the 22q11.2DS patients from
which surgeons can make adjustments in their technique
in hopes of decreasing the revision rate.
In addition to the above findings, the pattern or type
of velopharyngeal change during phonation is of interest.
That is, both balloon- and shelf-type closure patterns
were observed. However, a unique finding relative to
these closure patterns is that those with 22q11.2DS were
evenly divided, with 7 participants exhibiting a balloontype and 8 exhibiting shelf-type closure. In contrast,
within the NSCP reference group, 13 of the 15 patients
were identified to have a shelf-type closure. Based on
our review of the literature, we were unable to identify
previous reports of this type of closure pattern in
22q11.2DS patients. This finding raises questions about
unique structural differences that distinguish these two
patient groups. For example, it is clear that anatomical
differences will exist in association with this syndrome;
however, the physiologic changes that emerge are likely
to be quite variable. Additionally, the potential impact of
volitional, function compensation(s) add a further dimension to this important concern. For that reason,
additional exploration of this unique clinical population
and the resultant variations that exist are warranted.
Given the structural complexities of this anatomical region,
it is not unreasonable to suggest that minor variations in
structure may result in subtle dynamic alterations that may be
overlaid with active compensatory changes. At present, we are
not sure of the underlying mechanism of the balloon-type
closure pattern, nor can we comment on its clinical significance. It does, however, appear to be quantifiable when evaluating the individual data presented in Table 1, as well as when
considering those data relative to the NSCP reference group.
When the present body of data is evaluated collectively,
we anticipate additional explorations of this phenomenon
would offer an interesting and valuable area for future
study specific to both the visualization and measurement
of the system and its impact on speech production. Defects within the velopharyngeal system will have real and
direct influences on the acoustic structure of speech [30].
Consequently, detailed analyses of the acoustic properties
of speech in those with 22q11.2DS may offer valuable insights into how changes similar to those we have documented influence intelligibility [31].
Although we believe the present study has provided
valuable insights into the unique characteristics of patients with 22q11.2DS, several limitations deserve
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explicit mention. First, it is important to note that our
results are limited by the relatively small number of patients. This reflects the phenotypic variability of the disease; that is, not all 22q11.2DS patients present with
VPD that is severe enough to warrant referral to a tertiary VPD clinic. Furthermore, MVV is not universally
used for patients with VPD since the diagnosis can also
be achieved through nasopharyngoscopy [32]. We acknowledge that MVV and nasopharyngoscopy each present
distinct advantages and disadvantages over each other.
However, MVV was specifically chosen for this study because of its ability to more objectively quantify velopharyngeal measures in contrast to nasopharyngoscopy’s
inherently more subjective interpretative evaluation which
makes quantification of measurements much more difficult.
Nevertheless, we wholeheartedly agree that clinicians
should take advantage of both modalities of assessment as
they provide crucial complimentary information required
for adequate surgical management of VPD. Although our
study lacks the presence of healthy controls, the comparison to those diagnosed with NSCP-related VPD provides
valuable insight into the velopharyngeal characteristics that
may contribute to the observed differences in postsurgical
outcomes exhibited between these two groups. Despite the
lack of exclusions regarding the presence of comorbidities
or type of cleft palate, we feel that our study’s external validity is preserved as clinicians would regularly encounter
similar challenges with heterogenous non-syndromic and
22q11.2DS cohorts. Nevertheless, this study is limited by
the same factors that challenge many efforts which seek to
gather information on clinical populations that are small in
the context of otolaryngology. In this regard, findings must
always be evaluated and interpreted with care; findings on
limited albeit unique clinical populations have restriction
specific to external validity. However, data such as ours suggest a starting point from which additional work can be
replicated and hopefully verified.
Our study objectively quantifies dynamic velopharyngeal
features in 22q11.2DS patients with VPD and improves
our understanding of the distinct velopharyngeal features
and deficiencies of this population. Given that different
surgical approaches for VPD correction affect static and
dynamic velopharyngeal function uniquely, one may consider complementing the unique velopharyngeal deficits of
22q11.2DS with the advantages of a specific surgical technique; however, further research investigating VPD surgical techniques and posttreatment outcomes in patients
diagnosed with 22q11.2DS is required. Finally, additional
details on speech performance and its consistency within
across participants is necessary in future work.

Conclusion
The current study has provided objective data on dynamic
features of VPD in those with 22q11.2DS. Our findings
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revealed that patterns of VPD differ between those with
and without 22q11.2DS. In particular, the LWD was found
to be significantly reduced in patients with 22q11.2DS
when data obtained from those with VPD secondary to
NSCP served as a point of reference. These data provide
valuable initial insights into the identification and description of the dynamic velopharyngeal function and its variability in association with 22q11.2DS-related VPD, as well
as differences potentially underlying discrepant postsurgical
outcomes. However, due to our relatively small sample size,
the interpretation and extension of these data must be done
with care. For that reason, additional investigation into the
velopharyngeal characteristics of patients with 22q11.2DS
may permit a more comprehensive understanding of the
structural and functional deficits that influence postsurgical
and speech outcomes and may serve surgeons in identifying
optimal surgical management for this unique population.
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